Study Links Wealth Taxes on Billionaires to Millions of Lives Saved by 2030

A new analysis published in The Lancet warns that targeted taxes on the world’s ultra‑rich, combined with systematic wealth redistribution, could prevent between 6.6 million and 29.5 million premature deaths by the end of the decade, offering a stark counterpoint to the ongoing erosion of official development assistance.

The research, coordinated by the public‑health institute ISGlobal and a coalition of economists and epidemiologists, modelled several policy scenarios. At the modest end, a modest global levy on fortunes above $1 billion could generate enough additional resources to avert 6.6 million deaths, while more aggressive fiscal reforms could push the figure toward 29.5 million, the study says.

According to the authors, the bulk of the health impact would stem from channeling the extra revenue into primary‑care infrastructure, vaccination programmes, nutrition support and disease‑prevention initiatives in low‑ and middle‑income nations. These interventions are known to deliver high returns in life expectancy, especially where existing health systems are underfunded.

The findings arrive at a moment when official development assistance (ODA) has been on a downward trajectory. After a brief surge during the COVID‑19 pandemic, donor budgets are tightening amid fiscal pressures in Europe, North America and parts of Asia. The resulting shortfall is already being felt in programs that address maternal health, child nutrition and infectious disease control, amplifying the vulnerability of the poorest populations.

Policy makers are now debating how to translate the study’s numbers into action. Proposals under consideration at the G20 and United Nations forums include a 2 percent annual tax on net fortunes exceeding $1 billion, coupled with a global coordination mechanism to ensure the proceeds are earmarked for health‑related development goals. While many civil‑society groups have welcomed the idea as a moral and pragmatic response to rising mortality, some high‑income governments have voiced concerns about sovereignty and the potential economic ripple effects of such taxes.

The authors caution that the mortality estimates rely on assumptions about how efficiently the raised funds would be deployed. Nonetheless, they argue that the health argument adds a compelling layer to the fiscal debate, shifting it beyond pure economics to the realm of human lives. As nations grapple with shrinking aid budgets, the study suggests that a coordinated wealth‑tax approach could become a lifeline for millions, provided political will aligns with the evidence.